SCHEMBL40887

SCHEMBL40887

C#CCC(N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1429407 1.00
SCHEMBL254259 1.00
Hydrochloric Acid SCHEMBL22778013 0.97
Hydrochloric Acid SCHEMBL22778011 0.97
Hydrochloric Acid SCHEMBL29956197 0.97
SCHEMBL2650618 0.81 GRIK1 (0.47)
SCHEMBL7700595 0.80 GRIK1 (1.00)
SCHEMBL27773703 0.80 GRIK1 (0.66)
SCHEMBL15310777 0.80 GRIK1 (1.00)
SCHEMBL7785618 0.80 GRIK1 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6812 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122074077-A Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte stimulating hormone analogs for imaging or therapy 省卫生服务机构 2026-05-22 CN claimed
US-12590137-B2 Meditope-enabled T cells CITY OF HOPE (US) 2026-03-31 US claimed
US-20260078158-A1 COMPOSITIONS COMPRISING CXCL10-DERIVED PEPTIDES AND METHODS OF USE THEREOF UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2026-03-19 US claimed
CN-121570433-A Glutamine metabolism regulation nano drug delivery system for enhancing pancreatic cancer targeting and penetration, and preparation method and application thereof 复旦大学 2026-02-27 CN claimed
EP-4652459-A2 CALCIUM INDEPENDENT PHOSPHATIDYLSERINE BINDING COMPOUNDS FOR DETECTING PHOSPHATIDYLSERINE POSITIVE CELLS Biolegend, Inc. (US) 2025-11-26 EP claimed
US-12480950-B2 AKT-specific capture agents, compositions, and methods of using and making REGENERON PHARMACEUTICALS, INC. (US) 2025-11-25 US claimed
US-12428447-B2 Peptide-based non-proteinaceous cargo delivery FELDAN BIO INC. (CA) 2025-09-30 US claimed
US-20250161351-A1 CANCER TREATMENT BY ARSENIC TRIOXIDE COMBINATION THERAPY Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2025-05-22 US claimed
EP-4543907-A1 GQ/11 PROTEIN PEPTIDOMIMETICS Vrije Universiteit Brussel (BE) 2025-04-30 EP claimed
US-12280038-B2 L-pag derivatives for treatment of sleep disordered breathing (SDB) THE UNIVERSITY OF CHICAGO (US) 2025-04-22 US claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
US-5614522-A SULFONAMIDE AND UREA-CONTAINING HYDROXYETHYLAMINE COMPOUNDS G.D. SEARLE & CO. (US) 1997-03-25 US claimed
EP-0750489-A1 INHIBITION OF HAIR GROWTH HANDELMAN, Joseph H. (US) 1997-01-02 EP claimed
US-5455234-A Applying inhibitor of cysteine pathway enzyme topically to skin; cosmetic for face, arms, legs AHLUWALIA GURPREET S (US) 1995-10-03 US claimed
WO-1995024885-A1 INHIBITION OF HAIR GROWTH HANDELMAN, JOSEPH, H. (US) 1995-09-21 WO claimed
WO-1992018118-A1 MEDICAMENTS STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY AND OREGON STATE UNIVERSITY (US) 1992-10-29 WO claimed
US-4801535-A DETECTION OF ASPARTATE AMINOTRANSFERASE XYTRONYX, INC. (US) 1989-01-31 US claimed
EP-0263145-A4 METHOD FOR DETECTION OF PERIODONTAL DISEASE. XYTRONYX INC (US) 1989-01-26 EP claimed
EP-0263145-A1 METHOD FOR DETECTION OF PERIODONTAL DISEASE XYTRONYX, INC. (US) 1988-04-13 EP claimed
WO-1987005633-A1 METHOD FOR DETECTION OF PERIODONTAL DISEASE XYTRONYX, INC. (US) 1987-09-24 WO claimed